孕期免疫激活致子代孤独症谱系障碍发生机制的研究进展

王琎; 沈珂馨; 陈洁; 丁媛

doi:10.11852/zgetbjzz2024-0784

PDF(448 KB)

中国儿童保健杂志 ›› 2025, Vol. 33 ›› Issue (11) : 1252-1255. DOI: 10.11852/zgetbjzz2024-0784

综述

孕期免疫激活致子代孤独症谱系障碍发生机制的研究进展

王琎, 沈珂馨, 陈洁, 丁媛

作者信息 +

Advances in mechanisms underlying autism spectrum disorder in offspring induced by maternal immune activation

WANG Jin, SHEN Kexin, CHEN Jie, DING Yuan

Author information +

文章历史 +

摘要

孤独症谱系障碍(ASD)是一组以社交障碍和重复刻板行为为核心症状的神经发育障碍性疾病,由遗传及环境因素共同作用而成。母体免疫激活(MIA)被认为是ASD发生的重要危险因素之一。近年来关于MIA导致子代ASD发生的相关机制研究发现,ASD的发病可能与MIA诱导的代谢失调、肠道菌群紊乱、表观遗传改变及神经炎症等有关,但其机制尚不十分明确,因此本文拟综述MIA导致子代ASD发病风险增高的相关机制,为ASD的病因及发病机制研究提供一定的理论支持。

Abstract

Autism spectrum disorder(ASD) is a neurodevelopmental disorder primarily characterized by social impairments and repetitive, stereotyped behaviors, resulting from the combined effects of genetic and environmental factors. Maternal immune activation (MIA) has been recognized as one of the significant risk factors for the occurrence of ASD in offspring. Recent studies have implicated MIA in metabolic disorder, disrupted gut microbiota, epigenetic alterations, and neuroinflammation associated with ASD. However, the specific underlying mechanisms remain elusive. Therefore, this study aims to provide theoretical support for the etiology research of ASD by comprehensively reviewing the mechanisms pertaining to the elevated risk of ASD associated with MIA.

导出引用

王琎, 沈珂馨, 陈洁, 丁媛. 孕期免疫激活致子代孤独症谱系障碍发生机制的研究进展[J]. 中国儿童保健杂志. 2025, 33(11): 1252-1255 https://doi.org/10.11852/zgetbjzz2024-0784

WANG Jin, SHEN Kexin, CHEN Jie, DING Yuan. Advances in mechanisms underlying autism spectrum disorder in offspring induced by maternal immune activation[J]. Chinese Journal of Child Health Care. 2025, 33(11): 1252-1255 https://doi.org/10.11852/zgetbjzz2024-0784

中图分类号： R179

参考文献

[1] Zeidan J, Fombonne E, Scorah J, et al. Global prevalence of autism: A systematic review update[J]. Autism Res, 2022, 15(5): 778-790.
[2] Zhou H, Xu X, Yan W, et al. Prevalence of autism spectrum disorder in China: A nationwide multi-center population-based study among children aged 6 to 12 years[J]. Neurosci Bull, 2020, 36(9): 961-971.
[3] Maenner MJ, Warren Z, Williams AR, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years-autism and developmental disabilities monitoring network, 11 sites, united states, 2020[J]. MMWR Surveill Summ, 2023, 72(2): 1-14.
[4] Courchesne E, Pramparo T, Gazestani VH, et al. The asd living biology: From cell proliferation to clinical phenotype[J]. Mol Psychiatry, 2019, 24(1): 88-107.
[5] Loayza M, Lin S, Carter K, et al. Maternal immune activation alters fetal and neonatal microglia phenotype and disrupts neurogenesis in mice[J]. Pediatr Res, 2023, 93(5): 1216-1225.
[6] Zawadzka A, Cies′lik M, Adamczyk A. The role of maternal immune activation in the pathogenesis of autism: A review of the evidence, proposed mechanisms and implications for treatment[J]. Int J Mol Sci, 2021, 22(21):11516.
[7] Watanabe S, Kurotani T, Oga T, et al. Functional and molecular characterization of a non-human primate model of autism spectrum disorder shows similarity with the human disease[J]. Nat Commun, 2021, 12(1): 5388.
[8] Xu Z, Zhang X, Chang H, et al. Rescue of maternal immune activation-induced behavioral abnormalities in adult mouse offspring by pathogen-activated maternal T(reg) cells[J]. Nat Neurosci, 2021, 24(6): 818-830.
[9] Smith SE, Li J, Garbett K, et al. Maternal immune activation alters fetal brain development through interleukin-6[J]. J Neurosci, 2007, 27(40): 10695-10702.
[10] Han VX, Patel S, Jones HF, et al. Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: A systematic review[J]. Transl Psychiatry, 2021, 11(1): 71.
[11] Bölte S, Girdler S, Marschik PB. The contribution of environmental exposure to the etiology of autism spectrum disorder[J]. Cell Mol Life Sci, 2019, 76(7): 1275-1297.
[12] Rowland J, Wilson CA. The association between gestational diabetes and asd and adhd: A systematic review and meta-analysis[J]. Sci Rep, 2021, 11(1): 5136.
[13] Yasumatsu K, Nagao JI, Arita-Morioka KI, et al. Bacterial-induced maternal interleukin-17a pathway promotes autistic-like behaviors in mouse offspring[J]. Exp Anim, 2020, 69(2): 250-260.
[14] Gzieło K, Piotrowska D, Litwa E, et al. Maternal immune activation affects socio-communicative behavior in adult rats[J]. Sci Rep, 2023, 13(1): 1918.
[15] Hughes HK, Moreno RJ, Ashwood P. Innate immune dysfunction and neuroinflammation in autism spectrum disorder (asd)[J]. Brain Behav Immun, 2023, 108: 245-254.
[16] Saghazadeh A, Ataeinia B, Keynejad K, et al. A meta-analysis of pro-inflammatory cytokines in autism spectrum disorders: Effects of age, gender, and latitude[J]. J Psychiatr Res, 2019, 115: 90-102.
[17] Matta SM, Hill-Yardin EL, Crack PJ. The influence of neuroinflammation in autism spectrum disorder[J]. Brain Behav Immun, 2019, 79: 75-90.
[18] Bergdolt L, Dunaevsky A. Brain changes in a maternal immune activation model of neurodevelopmental brain disorders[J]. Prog Neurobiol, 2019, 175: 1-19.
[19] Boktor JC, Adame MD, Rose DR, et al. Global metabolic profiles in a non-human primate model of maternal immune activation: Implications for neurodevelopmental disorders[J]. Mol Psychiatry, 2022, 27(12): 4959-4973.
[20] Yin H, Wang Z, Liu J, et al. Dysregulation of immune and metabolism pathways in maternal immune activation induces an increased risk of autism spectrum disorders[J]. Life Sci, 2023, 324: 121734.
[21] Castora FJ. Mitochondrial function and abnormalities implicated in the pathogenesis of ASD[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2019, 92: 83-108.
[22] Naviaux JC, Wang L, Li K, et al. Antipurinergic therapy corrects the autism-like features in the fragile x (fmr1 knockout) mouse model[J]. Molecular autism,2015,6: 1-20.
[23] McColl ER, Piquette-Miller M. Poly(i:C) alters placental and fetal brain amino acid transport in a rat model of maternal immune activation[J]. Am J Reprod Immunol, 2019, 81(6): e13115.
[24] Ahmed H, Leyrolle Q, Koistinen V, et al. Microbiota-derived metabolites as drivers of gut-brain communication[J]. Gut Microbes, 2022, 14(1): 2102878.
[25] Needham BD, Funabashi M, Adame MD, et al. A gut-derived metabolite alters brain activity and anxiety behaviour in mice[J]. Nature, 2022, 602(7898): 647-653.
[26] Wang Y, Li N, Yang JJ, et al. Probiotics and fructo-oligosaccharide intervention modulate the microbiota-gut brain axis to improve autism spectrum reducing also the hyper-serotonergic state and the dopamine metabolism disorder[J]. Pharmacol Res, 2020, 157: 104784.
[27] Wang Q, Yang Q, Liu X. The microbiota-gut-brain axis and neurodevelopmental disorders[J]. Protein Cell, 2023, 14(10): 762-775.
[28] Maldonado-Ruiz R, Garza-Ocañas L, Camacho A. Inflammatory domains modulate autism spectrum disorder susceptibility during maternal nutritional programming[J]. Neurochem Int, 2019, 126: 109-117.
[29] Potter HG, Kowash HM, Woods RM, et al. Maternal behaviours and adult offspring behavioural deficits are predicted by maternal tnfα concentration in a rat model of neurodevelopmental disorders[J]. Brain Behav Immun, 2023, 108: 162-175.
[30] Gumusoglu SB, Hing BWQ, Chilukuri ASS, et al. Chronic maternal interleukin-17 and autism-related cortical gene expression, neurobiology, and behavior[J]. Neuropsychopharmacology, 2020, 45(6): 1008-1017.
[31] Udagawa J, Hino K. Impact of maternal stress in pregnancy on brain function of the offspring[J]. Nihon eiseigaku zasshi Japanese journal of hygiene, 2016, 71(3): 188-194.
[32] Lombardo MV, Moon HM, Su J, et al. Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder[J]. Mol Psychiatry, 2018, 23(4): 1001-1013.
[33] Wei H, Zou H, Sheikh AM, et al. Il-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation[J]. J Neuroinflammation, 2011, 8: 52.
[34] Lampiasi N, Bonaventura R, Deidda I, et al. Inflammation and the potential implication of macrophage-microglia polarization in human asd: An overview[J]. International Journal of Molecular Sciences, 2023, 24(3): 2703.
[35] Fan G, Ma J, Ma R, et al. Microglia modulate neurodevelopment in autism spectrum disorder and schizophrenia[J]. Int J Mol Sci, 2023, 24(24):17297.
[36] Bjørklund G, Mkhitaryan M, Sahakyan E, et al. Linking environmental chemicals to neuroinflammation and autism spectrum disorder: Mechanisms and implications for prevention[J]. Molecular Neurobiology, 2024: 1-13.
[37] Estes ML, McAllister AK. Maternal immune activation: Implications for neuropsychiatric disorders[J]. Science, 2016, 353(6301): 772-777.
[38] Money KM, Barke TL, Serezani A, et al. Gestational diabetes exacerbates maternal immune activation effects in the developing brain[J]. Mol Psychiatry, 2018, 23(9): 1920-1928.
[39] Vuillermot S, Luan W, Meyer U, et al. Vitamin d treatment during pregnancy prevents autism-related phenotypes in a mouse model of maternal immune activation[J]. Mol Autism, 2017, 8: 9.
[40] Morais LH, Schreiber HLT, Mazmanian SK. The gut microbiota-brain axis in behaviour and brain disorders[J]. Nat Rev Microbiol, 2021, 19(4): 241-255.